X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Indoco Remedies with Indiabulls Fin. Ser. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs INDIABULLS FIN. SER. - Comparison Results

INDOCO REMEDIES    Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

INDIABULLS FIN. SER. 
   Change

Indiabulls Financial Services Ltd. (IBFS) operates in financial services and real estate business in India. The company hived off its real estate business on December 2006 to form a new company Indiabulls Real Estate Ltd. Now, IBFS provides various f... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES INDIABULLS FIN. SER. INDOCO REMEDIES/
INDIABULLS FIN. SER.
 
P/E (TTM) x 31.4 7.1 439.2% View Chart
P/BV x 3.7 1.6 226.7% View Chart
Dividend Yield % 0.6 7.3 8.3%  

Financials

 INDOCO REMEDIES   INDIABULLS FIN. SER.
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-17
INDIABULLS FIN. SER.
Mar-13
INDOCO REMEDIES/
INDIABULLS FIN. SER.
5-Yr Chart
Click to enlarge
High Rs360NA-   
Low Rs249NA-   
Sales per share (Unadj.) Rs119.0151.3 78.6%  
Earnings per share (Unadj.) Rs8.440.3 20.8%  
Cash flow per share (Unadj.) Rs15.240.6 37.5%  
Dividends per share (Unadj.) Rs1.6020.00 8.0%  
Dividend yield (eoy) %0.5NM- 
Book value per share (Unadj.) Rs70.7165.4 42.8%  
Shares outstanding (eoy) m92.15312.51 29.5%   
Bonus/Rights/Conversions -A,ESOP-  
Price / Sales ratio x2.60-   
Avg P/E ratio x36.40-  
P/CF ratio (eoy) x20.00-  
Price / Book Value ratio x4.30-  
Dividend payout %19.149.7 38.5%   
Avg Mkt Cap Rs m28,0830-   
No. of employees `0006.0NA-   
Total wages/salary Rs m2,1672,246 96.5%   
Avg. sales/employee Rs Th1,817.0NM-  
Avg. wages/employee Rs Th359.0NM-  
Avg. net profit/employee Rs Th127.7NM-  
INCOME DATA
Net Sales Rs m10,96847,294 23.2%  
Other income Rs m40485 8.2%   
Total revenues Rs m11,00747,780 23.0%   
Gross profit Rs m1,56542,151 3.7%  
Depreciation Rs m63394 674.6%   
Interest Rs m6225,991 0.2%   
Profit before tax Rs m90916,551 5.5%   
Minority Interest Rs m0-76 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1393,891 3.6%   
Profit after tax Rs m77112,585 6.1%  
Gross profit margin %14.389.1 16.0%  
Effective tax rate %15.323.5 64.9%   
Net profit margin %7.026.6 26.4%  
BALANCE SHEET DATA
Current assets Rs m5,725112,654 5.1%   
Current liabilities Rs m5,454152,031 3.6%   
Net working cap to sales %2.5-83.3 -3.0%  
Current ratio x1.00.7 141.7%  
Inventory Days Days620-  
Debtors Days Days720 41,519.7%  
Net fixed assets Rs m5,307456 1,163.6%   
Share capital Rs m184625 29.5%   
"Free" reserves Rs m6,33136,841 17.2%   
Net worth Rs m6,51651,686 12.6%   
Long term debt Rs m1,323182,345 0.7%   
Total assets Rs m11,970391,288 3.1%  
Interest coverage x15.61.6 955.8%   
Debt to equity ratio x0.23.5 5.8%  
Sales to assets ratio x0.90.1 758.1%   
Return on assets %7.09.9 70.6%  
Return on equity %11.824.3 48.6%  
Return on capital %12.418.1 68.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m4,5070-   
Fx outflow Rs m1,14168 1,676.1%   
Net fx Rs m3,366-68 -4,942.0%   
CASH FLOW
From Operations Rs m886-36,088 -2.5%  
From Investments Rs m-1,706-993 171.8%  
From Financial Activity Rs m1,31652,273 2.5%  
Net Cashflow Rs m49715,193 3.3%  

Share Holding

Indian Promoters % 59.2 37.0 160.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 12.5 2.7 463.0%  
FIIs % 6.0 37.9 15.8%  
ADR/GDR % 0.0 1.1 -  
Free float % 22.4 21.3 105.2%  
Shareholders   12,805 80,530 15.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   TATA INVEST. CORP.  CCL INTERNATIONAL  IL&FS INV. MANAGERS  CREST VENTURES  EDELWEISS FINANCIAL  



Today's Market

Sensex Finishes Firm; Software & FMCG Stocks Gain(Closing)

Indian share markets finished the trading session well above the dotted line, snapping a three-day falling streak amid firm Asian markets.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Feb 21, 2018 03:35 PM

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES 8-QTR ANALYSIS

COMPARE INDOCO REMEDIES WITH

MARKET STATS